AR055111A1 - Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano - Google Patents

Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano

Info

Publication number
AR055111A1
AR055111A1 ARP060103433A ARP060103433A AR055111A1 AR 055111 A1 AR055111 A1 AR 055111A1 AR P060103433 A ARP060103433 A AR P060103433A AR P060103433 A ARP060103433 A AR P060103433A AR 055111 A1 AR055111 A1 AR 055111A1
Authority
AR
Argentina
Prior art keywords
salt
benzoate salt
alzheimer
disease
metiloxazolo
Prior art date
Application number
ARP060103433A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR055111A1 publication Critical patent/AR055111A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente proporciona una sal benzoato de formula (1), la formula también es conocida como 4-(5-metiloxazolo[4,5-b]piridin-2-il)-1,4- diazabiciclo[3.2.2]nonano. La sal benzoato es util en el tratamiento de esquizofrenia y enfermedad de Alzheimer. Es particularmente util en el tratamiento de déficit cognitivos asociados a esquizofrenia, síntomas de déficit cognitivo y de atencion de la enfermedad de Alzheimer y neurodegeneracion asociada a la enfermedad de Alzheimer. Reivindicacion 2: La sal segun la reivindicacion 1, en la que la sal tiene picos de difraccion de rayos X en polvo característicos medidos con radiacion de cobre de 2-theta+-0,1° de 10,6, 12,9, 13,8,17,6 y 19,3.
ARP060103433A 2005-08-08 2006-08-07 Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano AR055111A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70660105P 2005-08-08 2005-08-08

Publications (1)

Publication Number Publication Date
AR055111A1 true AR055111A1 (es) 2007-08-08

Family

ID=37398316

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103433A AR055111A1 (es) 2005-08-08 2006-08-07 Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano

Country Status (6)

Country Link
AR (1) AR055111A1 (es)
DO (1) DOP2006000185A (es)
NL (1) NL1032286C2 (es)
TW (1) TW200738734A (es)
UY (1) UY29731A1 (es)
WO (1) WO2007017750A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009113950A1 (en) * 2008-03-10 2009-09-17 Astrazeneca Ab Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
US11337932B2 (en) 2016-12-20 2022-05-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
US20180193283A1 (en) 2016-12-20 2018-07-12 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN107188900B (zh) * 2017-05-27 2019-09-06 北京师范大学 α7烟碱型乙酰胆碱受体的配体化合物及其应用
EP3644973B1 (en) 2017-06-26 2021-03-24 LTS LOHMANN Therapie-Systeme AG Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
JP2021529737A (ja) 2018-06-20 2021-11-04 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンを含有する経皮治療システム

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086871A1 (en) * 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
JP2007516275A (ja) * 2003-12-23 2007-06-21 ファイザー・プロダクツ・インク 認知増強および精神病性障害のための治療的組合せ

Also Published As

Publication number Publication date
NL1032286C2 (nl) 2007-08-07
DOP2006000185A (es) 2007-03-31
TW200738734A (en) 2007-10-16
WO2007017750A1 (en) 2007-02-15
UY29731A1 (es) 2007-03-30
NL1032286A1 (nl) 2007-02-09

Similar Documents

Publication Publication Date Title
AR055111A1 (es) Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano
NZ600430A (en) Spiro-oxindole mdm2 antagonists
TN2011000493A1 (en) 1-heterocyclyl -1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin -4- one derivatives and their use as pde9a modulators
MX2011008452A (es) Derivados de triazolo [4,3-b] piridazina y sus usos para el cancer de prostata.
GEP20166554B (en) Nitrogenated heterocyclic compound
HK1143810A1 (en) Imidazo [1,2-a] pyrazine compounds for treatment of viral infections such as hepatitis
TN2013000324A1 (en) 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one derivatives their use as pde9a inhibitors
ATE465163T1 (de) Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
CL2012000923A1 (es) Procedimiento para la preparacion de un polimero fotoprotector progresivo de organosilicio; polimero obtenido en forma de micro o nanoparticula; composicion cosmetica o dermatologica; monomero; procedimiento de preparacion del monomero; uso del polimero como precursor fotoquimico de absorbedores de uv como filtro solar.
EP2134736A4 (en) FIVE- AND SIX-PIECE CONFORMATIVELY FIXED 2 ', 4'-CARBOCYCLIC RIBOTHYMIDINE FOR THE TREATMENT OF INFECTIONS AND CANCER
WO2007059064A3 (en) Fgf2-related methods for diagnosing and treating depression
TNSN07165A1 (en) Organic compounds
NZ627558A (en) Heterocyclic piperidine compounds and methods of their use
NZ603895A (en) Novel phosphodiesterase inhibitors
GB0706335D0 (en) Porphyrin compounds
WO2012107488A3 (en) Metal-free photosensitizers
WO2012013850A3 (es) Compuesto para tratar enfermedades neurodegenerativas, déficits cognitivos y/o demencias
TH155601A (th) ผลึกของสารประกอบฟิวสด์ เฮเทอโรไซคลิค
Liver Cancer Study Group et al. Expert consensus on the scheme of pathological diagnosis of primary liver cancer
ES1070114Y (es) Ropa de cama absorbente, impermeable y transpirable
Díaz-Gallifa et al. Neutron diffraction studies on metal-organic magnetic solid solution. Searching for the tunable magnetic material
Kojima Current aspects of LLNA-DA and LLNA-BrdU as alternatives for skin sensitizer classification in Japan
UA106368C2 (en) 1-heterocyclyl-1,5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
TH117300B (th) ที่นั่งสำหรับรถเข็นเด็ก
TH121813B (th) ชิ้นส่วนอุปกรณ์ล็อคเกียร์สำหรับรถยนต์

Legal Events

Date Code Title Description
FB Suspension of granting procedure